Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Verona Pharma Plc ADR shares valued at $1,275,681 were sold by ZACCARDELLI DAVID on Aug 13 ’24. At $3.20 per share, ZACCARDELLI DAVID sold 398,400 shares. The insider’s holdings dropped to 15,850,704 shares worth approximately $443.66 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, ZACCARDELLI DAVID sold 1,600 shares, netting a total of over 5,008 in proceeds. Following the sale of shares at $3.13 each, the insider now holds 16,249,104 shares.
Before that, Hahn Mark W had sold 398,400 shares from its account. In a trade valued at $1,275,540, the Chief Financial Officer traded Verona Pharma Plc ADR shares for $3.20 each. Upon closing the transaction, the insider’s holdings decreased to 398,400 shares, worth approximately $418.16 million.
As of August 26, 2022, Piper Sandler has initiated its “an Overweight” rating for VRNA. Earlier on September 13, 2021, H.C. Wainwright initiated its rating. Their recommendation was “a Buy” for VRNA stock.
Analyzing VRNA Stock Performance
During the last five days, there has been a surge of approximately 2.49%. Over the course of the year, Verona Pharma Plc ADR shares have jumped approximately 40.79%. Shares of the company reached a 52-week high of $28.83 on 08/15/24 and a 52-week low of $11.39 on 05/30/24. A 50-day SMA is recorded $20.17, while a 200-day SMA reached $16.92. Nevertheless, trading volume fell to 1.0 million shares from 1.06 million shares the previous day.
Support And Resistance Levels for Verona Pharma Plc ADR (VRNA)
According to the 24-hour chart, there is a support level at 27.57, which, if violated, would cause prices to drop to 27.15. In the upper region, resistance lies at 28.22. The next price resistance is at 28.45. RSI (Relative Strength Index) is 73.10 on the 14-day chart, showing overbought technical sentiment. Moving Average Convergence Divergence (MACD) is at 3.23, which suggests the price will increase in the coming days. Percent R is at 8.14%, indicating bullish price movement. Stochastics%K at selling indicates that the stock is to be held.
